Former United States Securities and Exchange Commission attorney
and the securities litigation firm of
Powers Taylor, LLP
are investigating the sale of Epocrates, Inc. (“Epocrates”) (NasdaqGS: EPOC) to athenahealth, Inc. for shareholders. Under the terms of the proposed deal valued at approximately $293 million, Epocrates shareholders will only receive $11.75 in cash for each share of Epocrates stock owned, well below at least one analysts’ estimated value of $15.00 per share.
If you are an affected investor, and you want to learn more about the lawsuit or join the action, contact Zach Groover at Powers Taylor, LLP, toll free (877) 728-9607, via email at
or Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 239-4568, or via email at
. There is no cost or fee to you.
The Epocrates sale investigation centers on whether Epocrates’ shareholders are receiving adequate compensation for their shares in the buyout, whether the transaction undervalues Epocrates’ stock, and whether Epocrates’ board attempted to obtain the highest share price for all shareholders prior to agreeing to the deal. Notably, at least one analyst with Yahoo! Finance has estimated that the true inherent value of Epocrates could be as high as $15.00 per share, well above the proposed sale price. Shareholder rights attorney Willie Briscoe stated that “due to the proposed sale price, the size of the deal and other factors, we believe this transaction may undervalue Epocrates’ stock. Our proposed lawsuit will seek to obtain the highest share price for all shareholders.”
The Briscoe Law Firm, PLLC
is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.
Powers Taylor, LLP
is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.